Medical Professional Publications

Pharmacy and Therapeutics Committee Updates

(From the January 2017 Issue of MedStat)

The following actions were taken at the November Pharmacy & Therapeutics Committee meeting:

Medication stock list was APPROVED for the Eating Disorder ClinicSugammadex (Bridion®) was APPROVED for maintenance on the Formulary following a 6-month review

Standardized dose rounding rules were APPROVED for piperacillin/tazobactam

Insulin therapy guidelines were REMOVED from use as this information is now available in other policies and procedures

Aminoglycoside and vancomycin dosing guidelines were APPROVED; education is being developed

Asenapine (Saphris®) was APPROVED for maintenance on the Formulary following a 6-month review

Levonorgestrel (Plan B®) was ADDED to the Formulary; the monograph is posted on the P&T intranet site

Infliximab-dyyb (Inflectra®) IV administration guidelines were APPROVED

myChildren’s mobile app

iPhone and Android.

Download Today! »

Nationwide Children's Hospital
700 Children's Drive Columbus, Ohio 43205 614.722.2000